Journal of Cancer Metastasis and Treatment Receives First Journal Impact Factor of 1.9
On June 28, 2023, Clarivate Analytics announced in the Journal Citation Reports (JCR) that Journal of Cancer Metastasis and Treatment achieved its first impact factor of 1.9.
Data source: Clarivate Analytics.
Journal of Cancer Metastasis and Treatment is an international peer-reviewed, gold open access, online academic international journal founded by OAE Publishing Inc. (www.oaepublish.com/jcmt). Its primary objective is to serve as a premier platform for the sharing and exchange of academic knowledge in the field of cancer metastasis and treatment. This encompasses various aspects such as the occurrence, development, progression, metastasis, and treatment of neoplastic diseases. The journal has been indexed in ESCI, Scopus, CAS, Wanfang Data, CNKI, Dimensions, and Google Scholar.
The notable achievement of Journal of Cancer Metastasis and Treatment in attaining its first impact factor is a testament to the unwavering strong support received from authors, experts, and readers, for which the Editorial Office is sincerely grateful. This milestone not only acknowledges their invaluable contributions but also provides an opportunity for the Editorial Board and Office to further enhance the journal's quality, service, and impact.
With a steadfast commitment to publishing high-quality papers that advance scientific developments in oncology, Journal of Cancer Metastasis and Treatment will continue to uphold its standards of excellence. By serving as a platform for cutting-edge research in cancer metastasis and treatment, it aims to disseminate scientific research and lead scientific innovation in the field.
We highly recommend the following highly cited articles for your perusal:
1. Targeting the JAK/STAT pathway in solid tumors
Authors: Qureshy, Zoya;Johnson, Daniel E.;Grandis, Jennifer R.
2. Seaweeds' nutraceutical and biomedical potential in cancer therapy: a concise review
Authors: Cotas, Joao;Pacheco, Diana;Goncalves, Ana M. M.;Silva, Paulo;Carvalho, Loic G.;Pereira, Leonel
3. Research progress on KRAS mutations in colorectal cancer
Authors: Cefali, Marco;Epistolio, Samantha;Palmarocchi, Maria Celeste;Frattini, Milo;De Dosso, Sara
4. Extracellular RNAs as potential biomarkers for cancer
Authors: Happel, Christine;Ganguly, Aniruddha;Tagle, Danilo A.
5. The systemic hallmarks of cancer
Authors: Paul, Doru
